Insider · CIK 0001156207

GIVEN DOUGLAS B

Reports to the SEC for 4 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001156207

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−547 sh	$22.04	−$12.1K	124,167
2024-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,000 sh	$21.90	−$110K	124,714
2024-01-11	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,811 sh	$37.76	−$68.4K	130,811
2024-01-11	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,100 sh	$38.55	−$42.4K	129,711
2023-12-15	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+15K sh	$25.41	+$381K	132,622
2023-05-05	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−6,500 sh	$40.90	−$266K	117,635
2023-02-27	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−875 sh	$32.62	−$28.5K	13,000
2023-01-10	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+7,867 sh	—	—	124,135
2023-01-10	ARWRARROWHEAD PHARMACEUTICALS, INC. · Common StockA Award	Director	AAward	+4,593 sh	—	—	4,593
2022-01-07	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+6,400 sh	—	—	116,268
2021-12-28	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−655 sh	—	—	109,213
2021-12-28	ARWRARROWHEAD PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+655 sh	$66.37	+$43.5K	109,868
2021-09-09	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,000 sh	$65.24	−$326K	109,868
2021-06-22	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,500 sh	$89.21	−$401K	114,868
2021-02-22	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,125 sh	$88.73	−$99.8K	13,875
2021-01-15	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,000 sh	$83.28	−$250K	12,500
2021-01-04	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,000 sh	$76.08	−$304K	119,368
2021-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+9,500 sh	—	—	123,368
2020-12-22	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−35 sh	—	—	113,868
2020-12-21	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−200 sh	—	—	113,938
2020-12-21	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−35 sh	—	—	113,903
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−65 sh	—	—	114,673
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−65 sh	—	—	114,608
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−200 sh	—	—	114,408
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−200 sh	—	—	114,208
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−35 sh	—	—	114,173
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−35 sh	—	—	114,138
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−9,075 sh	$79.30	−$720K	114,738
2020-12-17	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$79.59	−$39.8K	15,000
2020-12-07	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−31K sh	—	—	123,813
2020-12-07	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	+15.5K sh	—	—	15,500
2020-12-07	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	+15.5K sh	—	—	15,500
2020-04-14	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−25K sh	$36.89	−$922K	155,925
2020-04-14	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−1,112 sh	—	—	154,813
2020-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+8,000 sh	—	—	180,925
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$5.19	+$156K	205,130
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	$2.19	+$39.4K	223,130
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$2.62	+$26.2K	233,130
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,000 sh	$4.75	+$33.3K	240,130
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−65K sh	$19.25	−$1.25M	175,130
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	35,000
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	17,000
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	7,000
2019-02-26	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,000 sh	—	—	0
2019-02-22	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,000 sh	$18.05	−$54.2K	175,130
2019-01-22	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,000 sh	$13.58	−$40.7K	178,130
2019-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+36K sh	—	—	181,130
2018-12-27	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,000 sh	$12.00	−$36K	145,130
2018-11-23	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,000 sh	$12.74	−$38.2K	148,130
2018-10-22	ARWRARROWHEAD PHARMACEUTICALS, INC.G Gift	Director	GGift	−3,870 sh	—	—	151,130

Recent filings

Accepted (ET)
Dec 184
GIVEN DOUGLAS B0001628280-24-051924
SEC(opens sec.gov)
Jan 164
GIVEN DOUGLAS B0001628280-24-001425
SEC(opens sec.gov)
Dec 194
GIVEN DOUGLAS B0001628280-23-041962
SEC(opens sec.gov)
May 84
GIVEN DOUGLAS B0001628280-23-016560
SEC(opens sec.gov)
Mar 14
GIVEN DOUGLAS B0001209191-23-014275
SEC(opens sec.gov)
Jan 114
GIVEN DOUGLAS B0001209191-23-003075
SEC(opens sec.gov)
Jan 74
GIVEN DOUGLAS B0001209191-22-002590
SEC(opens sec.gov)
Dec 294
GIVEN DOUGLAS B0001209191-21-071563
SEC(opens sec.gov)
Sep 104
GIVEN DOUGLAS B0001209191-21-055474
SEC(opens sec.gov)
Jun 244
GIVEN DOUGLAS B0001209191-21-043051
SEC(opens sec.gov)
Feb 244
GIVEN DOUGLAS B0001209191-21-013974
SEC(opens sec.gov)
Jan 194
GIVEN DOUGLAS B0001209191-21-004076
SEC(opens sec.gov)
Jan 54
GIVEN DOUGLAS B0001209191-21-001527
SEC(opens sec.gov)
Dec 294
GIVEN DOUGLAS B0001209191-20-065396
SEC(opens sec.gov)

Companies

Address

C/O VIA PHARMACEUTICALS, INC. 750 BATTERY STREET, SUITE 330

SAN FRANCISCO, CA, 94111